Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacoeconomics"
DOI: 10.1007/s40273-018-0646-1
Abstract: As part of the single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited Celgene Ltd to submit clinical and cost-effectiveness evidence for paclitaxel as albumin-bound nanoparticles (Nab-Pac) in combination… read more here.
Keywords: gem; nab pac; gem cap; pac gem ... See more keywords
Comparative Safety and Efficacy of Therapeutic Options in Resectable and Advanced/Metastatic Pancreatic Cancer: A Systematic Review and Indirect Comparison
Sign Up to like & getrecommendations! Published in 2021 at "Oncology Research and Treatment"
DOI: 10.1159/000517409
Abstract: Objectives: FOLFIRINOX, gemcitabine/nab-paclitaxel (gem-nab/P), and gemcitabine-capecitabine (gem-cap) demonstrated superiority over gemcitabine monotherapy for pancreatic cancer (PC). It is still unclear which chemotherapy regimen is the most optimal. This study aimed to conduct a systematic review… read more here.
Keywords: gem; gem nab; resectable advanced; gem cap ... See more keywords